Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

quantiferon   save search

QIAGEN launches QuantiFERON-EBV RUO assay, facilitating research of cell-mediated immune response to Epstein-Barr virus
Published: 2023-10-04 (Crawled : 20:00) - globenewswire.com
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.1% C: -0.1%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.1% C: -0.1%

research virus response
QIAGEN’s QuantiFERON solutions recommended for use by kidney specialists in Tunisia
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.81% C: 0.38%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.81% C: 0.38%

kidney solutions quantiferon
QIAGEN’s QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening
Published: 2023-06-15 (Crawled : 20:00) - globenewswire.com
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.42% C: -0.06%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.42% C: -0.06%

unique technology plus
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
Published: 2023-02-14 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.6% C: 0.08%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.6% C: 0.08%

blood test plus
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
Published: 2022-03-24 (Crawled : 09:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -1.23% H: 0.37% C: 0.27%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -1.23% H: 0.37% C: 0.27%

100 quantiferon milestone test
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
Published: 2022-02-07 (Crawled : 10:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 1.53% H: 0.0% C: 0.0%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 1.53% H: 0.0% C: 0.0%

chinese approval test quantiferon
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
Published: 2021-12-02 (Crawled : 09:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.88% C: 0.5%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.88% C: 0.5%

covid quantiferon t-cell sars-cov-2 response
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
Published: 2021-11-29 (Crawled : 08:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -4.74% H: 1.86% C: 1.05%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -4.74% H: 1.86% C: 1.05%

quantiferon fda fda approval test approval
QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions
Published: 2021-10-19 (Crawled : 22:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.75% C: 0.63%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.75% C: 0.63%

test
QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early diagnosis of Lyme Borreliosis
Published: 2021-04-21 (Crawled : 07:00) - biospace.com/
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -1.95% H: 1.5% C: 1.13%
QGEN | $39.47 0.61% 0.0% 950K twitter stocktwits trandingview |
Health Technology
| | O: -1.95% H: 1.5% C: 1.13%

partnership ce mark technology diagnostic
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.